Purpose The objective of this study was to evaluate the efficacy and tolerability of a triple
combination of amlodipine/losartan/rosuvastatin in patients with hypertension and …

Background Few data are available regarding the efficacy and safety of a single-pill
combination (SPC) consisting of four medications in patients with concomitant hypertension …

Background: This study was a multicenter, randomized, double-blinded, placebo-controlled
phase III clinical trial to investigate the efficacy and safety of an olmesartan/amlodipine …

This multicenter, randomized, double‐blind, parallel‐group phase III clinical trial aimed to
investigate the efficacy and safety of a rosuvastatin+ amlodipine combination compared with …

Background Blood pressure (BP) and low-density lipoprotein cholesterol (LDL-C) are
important risk factors for cardiovascular (CV) diseases. Although treating these factors …

Various single‐pill combinations (SPCs) have been introduced to improve drug compliance
and clinical efficacy. However, there is a lack of real‐world evidence regarding the …

Hypertension (HTN) and dyslipidemia (DYS) commonly coexist. Patients with concurrent
HTN and DYS are at high risk of cardiovascular disease, yet most patients do not achieve …

The aim was to evaluate the efficacy of a single-pill combination of atorvastatin/amlodipine
in patients with arterial hypertension, dyslipidemia and moderate to high cardiovascular risk …

Purpose Fixed-dose combination therapy with telmisartan, amlodipine, and rosuvastatin is
needed in patients with hypertension and dyslipidemia for better adherence and cost …

The pill burden of patients with hypertension and dyslipidemia can result in poor medication
compliance. This study aimed to evaluate the efficacy and safety of fixed-dose combination …